Simplex Trading
NYMX

Simplex Trading’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Simplex Trading’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,300
Closed -$6K – 11506
2022
Q1 		$6K Buy
5,300
+2,300
+77% +$3.55K ﹤0.01% 9364
2021
Q4 		$3K Sell
3,000
-5,100
-63% -$8.14K ﹤0.01% 9917
2021
Q3 		$12K Hold
8,100
– – ﹤0.01% 8848
2021
Q2 		$12K Buy
8,100
+8,039
+13,179% +$14.9K ﹤0.01% 9009
2021
Q1 		$13K Sell
61
-49
-45% -$129 ﹤0.01% 7775
2020
Q4 		$27K Buy
110
+3
+3% +$7 ﹤0.01% 6767
2020
Q3 		$26K Buy
107
+76
+245% +$221 ﹤0.01% 6196
2020
Q2 		$11K Sell
31
-42
-58% -$133 ﹤0.01% 6625
2020
Q1 		$17K Buy
73
+47
+181% +$132 ﹤0.01% 6105
2019
Q4 		$5K Buy
26
+20
+333% +$39 ﹤0.01% 6731
2019
Q3 		$1K Buy
+6
New +$10 ﹤0.01% 7105
2019
Q2 		– Sell
-49
Closed -$9K – 8023
2019
Q1 		$9K Sell
49
-404
-89% -$857 ﹤0.01% 6239
2018
Q4 		$59K Sell
453
-1,672
-79% -$3.06K ﹤0.01% 4377
2018
Q3 		$522K Sell
2,125
-24
-1% -$71 ﹤0.01% 2582
2018
Q2 		$722K Buy
2,149
+944
+78% +$3.63K ﹤0.01% 2100
2018
Q1 		$62K Sell
1,205
-525
-30% -$1.82K ﹤0.01% 2226
2017
Q4 		$47K Sell
1,730
-99
-5% -$361 ﹤0.01% 2517
2017
Q3 		$68K Buy
1,829
+538
+42% +$2.04K ﹤0.01% 2025
2017
Q2 		$66K Sell
1,291
-337
-21% -$1.38K ﹤0.01% 2130
2017
Q1 		$40K Buy
1,628
+714
+78% +$2.35K ﹤0.01% 2581
2016
Q4 		$58K Buy
914
+825
+927% +$2.56K ﹤0.01% 2012
2016
Q3 		$1K Buy
+89
New +$291 ﹤0.01% 5508
2016
Q1 		– Sell
-166
Closed -$9K – 6444
2015
Q4 		$9K Buy
+166
New +$557 ﹤0.01% 3436

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
CF
Corrigan Financial Middletown, Rhode Island $485M AUM 4.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's NYMX Position: Q4 2022 in Review

Simplex Trading sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2022, closing a stake of 1,113 shares — an estimated $403 sold.

Simplex Trading first reported a position in NYMX in Q3 2015 and held it in 23 quarters. The position peaked at $295K in Q3 2018. 37 funds tracked by Wall St. Rank hold NYMX as of Q4 2022.

  • Simplex Trading reported no remaining Nymox Pharmaceutical Corp position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 1,113 Nymox Pharmaceutical Corp shares in Q4 2022, an estimated $403.
  • Simplex Trading first reported a position in Nymox Pharmaceutical Corp in Q3 2015 and held it in 23 quarters.
  • Simplex Trading's Nymox Pharmaceutical Corp position peaked at $295K in Q3 2018.
  • 37 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.